As of the latest SEC filings, ARS Pharmaceuticals, Inc. (SPRY) is held by 144 institutional funds. The largest fund shareholder is State Street(R) SPDR(R) S&P(R) Biotech ETF (XBI), holding an estimated $17,774,453.18 in market value, representing 0.24% of its portfolio.
Funds holding ARS Pharmaceuticals, Inc. (SPRY)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- SPRY
- CIK:
- 0001671858
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 0.24% | $17,774,453.18 | 2,213,506 | Mar 31, 2026 | May 28, 2026 |
|
THQ
abrdn Healthcare Opportunities Fund
|
CEF | abrdn / Aberdeen | 1.99% | $14,322,532.84 | 1,783,628 | Mar 31, 2026 | May 29, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $14,050,596.89 | 1,749,763 | Mar 31, 2026 | May 28, 2026 |
|
HQH
abrdn Healthcare Investors
|
CEF | abrdn / Aberdeen | 1.09% | $12,430,552.42 | 1,548,014 | Mar 31, 2026 | May 29, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.02% | $11,642,504.28 | 1,449,876 | Mar 31, 2026 | May 28, 2026 |
|
BDFIX
BARON DISCOVERY FUND
|
MF | Independent / Boutique | 0.53% | $8,629,110.27 | 1,074,609 | Mar 31, 2026 | May 22, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.01% | $5,896,565.51 | 734,317 | Mar 31, 2026 | May 28, 2026 |
|
HQL
abrdn Life Sciences Investors
|
CEF | abrdn / Aberdeen | 0.91% | $5,127,195.15 | 638,505 | Mar 31, 2026 | May 29, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.01% | $4,822,427.54 | 583,829 | Apr 30, 2026 | Jun 26, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.03% | $3,831,361.93 | 477,131 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.05% | $3,721,134.12 | 463,404 | Mar 31, 2026 | May 28, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.01% | $3,187,132.48 | 343,441 | Feb 28, 2026 | Apr 24, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.06% | $3,110,247.68 | 335,156 | Feb 28, 2026 | Apr 24, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.01% | $2,932,591.36 | 316,012 | Feb 28, 2026 | Apr 24, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.02% | $2,714,808.32 | 292,544 | Feb 28, 2026 | Apr 28, 2026 |
|
WSMCX
Allspring Small Company Growth Fund
|
MF | Allspring | 0.47% | $2,447,933.60 | 296,360 | Apr 30, 2026 | Jun 24, 2026 |
|
VHCIX
VANGUARD HEALTH CARE INDEX FUND
|
ETF | Vanguard | 0.01% | $1,516,602.56 | 163,427 | Feb 28, 2026 | Apr 28, 2026 |
|
SMLF
iShares U.S. Small-Cap Equity Factor ETF
|
ETF | BlackRock / iShares | 0.04% | $1,396,452.12 | 169,062 | Apr 30, 2026 | Jun 26, 2026 |
|
FSKAX
Fidelity Total Market Index Fund
|
MF | Fidelity | 0.00% | $1,156,881.92 | 124,664 | Feb 28, 2026 | Apr 24, 2026 |
|
JSCZX
JPMorgan U.S. Small Company Fund
|
MF | JPMorgan | 0.12% | $1,088,859.97 | 135,599 | Mar 31, 2026 | May 29, 2026 |
|
SWSSX
Schwab Small-Cap Index Fund
|
MF | Charles Schwab | 0.01% | $1,047,814.04 | 126,854 | Apr 30, 2026 | Jun 25, 2026 |
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
ETF | Direxion | 0.20% | $1,045,848.16 | 126,616 | Apr 30, 2026 | Jun 29, 2026 |
|
KCSIX
Knights of Columbus Small Cap Equity Fund
|
MF | Independent / Boutique | 0.50% | $970,855.62 | 117,537 | Apr 30, 2026 | Jun 25, 2026 |
|
FCFMX
Fidelity Series Total Market Index Fund
|
MF | Fidelity | 0.00% | $878,017.92 | 94,614 | Feb 28, 2026 | Apr 24, 2026 |
|
SBIO
ALPS Medical Breakthroughs ETF
|
ETF | Independent / Boutique | 0.59% | $817,568.00 | 88,100 | Feb 28, 2026 | Apr 29, 2026 |
Advertisement (320x50)